Alessandro Piergentili Selected Research

Alessandro Piergentili Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 01/2020
3	Bulimia (Binge Eating) 01/2023 - 01/2019
3	Feeding and Eating Disorders (Eating Disorder) 01/2023 - 07/2020
3	Pain (Aches) 01/2023 - 11/2009
3	Prostatic Neoplasms (Prostate Cancer) 04/2019 - 12/2005
2	Obesity 01/2023 - 10/2021
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 07/2020
2	Neuralgia (Stump Neuralgia) 01/2020 - 09/2017
2	Breast Neoplasms (Breast Cancer) 04/2019 - 02/2010
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2019
2	Morphine Dependence 07/2012 - 11/2010
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Body Weight (Weight, Body) 10/2021
1	Bone Resorption 01/2021
1	Schizophrenia (Dementia Praecox) 01/2019
1	Dyskinesias (Dyskinesia) 01/2019
1	Xerostomia 08/2014
1	Depressive Disorder (Melancholia) 09/2013
1	Opioid-Related Disorders (Opiate Addiction) 09/2013
1	Salter-Harris Fractures 02/2013
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2012

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 01/2023 - 09/2017
4	5-HT1A Serotonin ReceptorIBA 04/2019 - 07/2012
3	1,4-dioxane (dioxane)IBA 04/2019 - 01/2019
3	Morphine (MS Contin)FDA LinkGeneric 11/2010 - 11/2009
2	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 04/2020
2	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2022 - 07/2020
2	CateninsIBA 01/2021 - 02/2013
2	N-Methylaspartate (NMDA)IBA 04/2020 - 04/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2020 - 04/2019
2	ImidazolinesIBA 01/2020 - 09/2017
1	NAD (NADH)IBA 01/2023
1	neuromedin UIBA 01/2023
1	Dopamine D3 ReceptorsIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Hormones (Hormone)IBA 10/2021
1	AcyltransferasesIBA 10/2021
1	GhrelinIBA 10/2021
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	EnzymesIBA 10/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 04/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	spipethianeIBA 01/2019
1	Yohimbine (Yocon)IBA 09/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2017
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 09/2017
1	Ion Channels (Ion Channel)IBA 12/2014
1	CalciumIBA 12/2014
1	cevimeline (Evoxac)FDA Link 08/2014
1	Opiate AlkaloidsIBA 09/2013
1	2- (1- (2- allylphenoxy)ethyl)- 4,5- dihydro- 1H- imidazoleIBA 07/2012
1	Naloxone (Narcan)FDA LinkGeneric 07/2012
1	Antidepressive Agents (Antidepressants)IBA 07/2012
1	Cytostatic AgentsIBA 02/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2009
1	AminesIBA 12/2005
1	(2- (2- (4- chlorobenzyloxy)phenoxy)ethyl)- (2- (2,6- dimethoxyphenoxy)ethyl)amineIBA 12/2005
1	lissamine rhodamine B (sulforhodamine B)IBA 12/2005

Therapy/Procedure

3	Analgesia 11/2010 - 11/2009
2	Therapeutics 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2021
1	Oral Administration 01/2020